$4.2 Billion - Boston Scientific Announces the Plan to Acquire BTG - 0 views
-
insightscare on 26 Nov 18Best known for developing stents to prop open clogged heart arteries - the US-based Boston Scientific Corp has formally announced its plan to buy UK's BTG Plc. for $4.2 billion, in its bid to extend its market share in the field of interventional medicine.